Effects of Administration of Phentonium Bromide on Opioid Withdrawal Syndrome in Rats

This study has tested whether phentonium bromide, a quaternary ammonium anti‐muscarinic agent, could reverse the signs of precipitated opioid withdrawal.

[1]  H. Bhargava.  Diversity of agents that modify opioid tolerance, physical dependence, abstinence syndrome, and self-administrative behavior. , 1994, Pharmacological reviews.

[2]  A. Cowan.  Effects of Opioids on the Spontaneous Behavior of Animals , 1993 .

[3]  Bhattacharya Sk,et al.  Thermic response of selective muscarinic agonists and antagonists in rat. , 1991 .

[4]  S. Bhattacharya,et al.  Thermic response of selective muscarinic agonists and antagonists in rat. , 1991, Indian journal of experimental biology.

[5]  A. Lapa,et al.  Phenthonium, a quaternary derivative of (−)−hyoscyamine, enhances the spontaneous release of acetylcholine at rat motor nerve terminals , 1990, British journal of pharmacology.

[6]  R. Viganò,et al.  A double-blind trial of fentonium bromide in the treatment of incontinent unstable bladder. , 1986, International journal of clinical pharmacology, therapy and toxicology.

[7]  J. Krystal,et al.  Multiple mechanisms of withdrawal from opioid drugs. , 1984, Annual review of neuroscience.

[8]  W. Turski,et al.  Studies on the mechanism of wet dog shakes produced by carbachol in rats. , 1984, Pharmacology.

[9]  A. Kruszewska,et al.  The role of central serotoninergic neurotransmission in the morphine abstinence syndrome in rats. , 1983, Drug and alcohol dependence.

[10]  J. Rupreht,et al.  Physostigmine versus naloxone in heroin-overdose. , 1983, Journal of toxicology. Clinical toxicology.

[11]  A. Tavani,et al.  Quaternary narcotic antagonists' relative ability to prevent antinociception and gastrointestinal transit inhibition in morphine-treated rats as an index of peripheral selectivity. , 1982, Life sciences.

[12]  D. Jasinski,et al.  Assessment of the Abuse Potential of Narcotic Analgesics in Animals , 1977 .

[13]  G. Benelli,et al.  [Analysis of the action of some substances on the visceral nerve endings]. , 1974, Bollettino chimico farmaceutico.

[14]  H. Loh,et al.  Cholinergic modification of naloxone-induced jumping in morphine dependent mice. , 1974, European journal of pharmacology.

[15]  K. Jhamandas,et al.  Modification of precipitated morphine withdrawal syndrome by drugs affecting cholinergic mechanisms. , 1973, European journal of pharmacology.

[16]  E. Domino,et al.  Enhanced Utilization of Brain Acetylcholine during Morphine Withdrawal in the Rat , 1973, Nature.

[17]  C. Pinsky,et al.  Morphine Withdrawal Syndrome Responses to Cholinergic Antagonists and to a Partial Cholinergic Agonist , 1973, Nature.

[18]  E. Way,et al.  Acetylcholinesterase inhibition and morphine effects in morphine tolerant and dependent mice. , 1972, The Journal of pharmacology and experimental therapeutics.

[19]  H. Collier,et al.  Modification of Morphine Withdrawal by Drugs interacting with Humoral Mechanisms: Some Contradictions and their Interpretation , 1972, Nature.

[20]  M. Sharkawi.  Morphine hyperthermia in the rat: its attenuation by physostigmine , 1972, British journal of pharmacology.

[21]  E. Lodola,et al.  Human pharmacology of phentonium, a new autonomic drug. , 1970, Current therapeutic research, clinical and experimental.

[22]  W. Large,et al.  The effect of acute and chronic morphine administration on brain acetylcholine levels in the rat. , 1970, British journal of pharmacology.

[23]  J. Kennedy,et al.  Narcotic-antagonist analgesics: interactions with cholinergic systems. , 1969, The Journal of pharmacology and experimental therapeutics.

[24]  Kakunaga Takeo,et al.  Pharmacological studies of analgesics—VI: The administration of morphine and changes in acetylcholine metabolism mouse brain , 1964 .